thetaOwl

LITE

Lumentum Holdings Inc.Close $938.00EOD only
Max Pain
$900.00
Next expiry Jun 5, 2026
Expected Move
±$35.65
3.8% from close
Price Gap
-38.00
Distance to max pain
IV Rank
20
Low premium
P/C OI
1.38
Slightly put-heavy
Consensus
5.0/10
Consensus signal
Published snapshot: Jun 3, 2026 close
End-of-day snapshot

This page reflects LITE options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot
Jun 3, 2026 close
LITE AI Consensus Report
Analysis based on market close June 4, 2026

Historical consensus-supported lens with full content, report chain context, and metric rail.

Conviction
7.0

out of 10

7 not 6 because strong flow and GEX alignment overcome the mean reversion risk; not 8 because conflict with theta reduces signal purity.

Where Perspectives Agree

Bullish pin near $900-$1000 with structural support at $800 gamma flip — flow accumulation, positive GEX, and theta selling opportunities all reinforce upside bias.

Where They Diverge

Theta's mean reversion risk (spot 5% above max pain) directly undermines the bullish continuation thesis if spot fades to $900 — contradicts aggressive call flow from institutional perspective.

Top Trade
via theta

Sell 2026-06-26 $835/$825 put spread for a credit of $2.50 — defined risk, profits from support pin.

Key Risk

Break below $800 gamma flip triggers dealer hedging and accelerates downside to $700 support.

How to Use These Reports
This ai consensus reflects the market close on June 4, 2026.
What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.